PSY16 COST-EFFECTIVENESS OF TOFACITINIB IN ACTIVE PSORIATIC ARTHRITIS AFTER CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS TREATMENT IN SPAIN
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2644
https://www.valueinhealthjournal.com/article/S1098-3015(19)35022-3/fulltext
Title :
PSY16 COST-EFFECTIVENESS OF TOFACITINIB IN ACTIVE PSORIATIC ARTHRITIS AFTER CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS TREATMENT IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)35022-3&doi=10.1016/j.jval.2019.09.2644
First page :
Section Title :
Open access? :
No
Section Order :
12323